Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings

Area of Science:

• Immunology
• Neurology
• Infectious Diseases

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• The role of infectious agents, such as Mycoplasma pneumoniae (MPn), in MS pathogenesis is under investigation.

Purpose of the Study:

• To investigate humoral and cellular immune reactions against Mycoplasma pneumoniae in multiple sclerosis patients.
• To assess the potential pathogenetic role of MPn in MS.

Main Methods:

• Analysis of complement-fixing antibodies in serum and cerebrospinal fluid (CSF).
• Evaluation of intrathecal antibody production by comparing serum and CSF antibody titres.
• Assessment of cellular immune sensitization using antigen-reactive active E-rosette assay, antibody-dependent cellular cytotoxicity, lymphocyte transformation test, and cell-mediated cytotoxicity assay.

Main Results:

• Humoral immune response: Complement-fixing antibodies against MPn were detected in serum and CSF of all 18 MS patients.
• Intrathecal antibody production: CSF antibody titres were comparable to or higher than serum titres, indicating local antibody synthesis within the central nervous system.
• Cellular immune response: All patients demonstrated sensitization to MPn via E-rosette and antibody-dependent cellular cytotoxicity assays. Lymphocyte transformation was observed in 17 patients, and cell-mediated cytotoxicity in 8 patients.

Conclusions:

• Multiple sclerosis patients exhibit significant humoral and cellular immune responses to Mycoplasma pneumoniae.
• The findings suggest a potential role for MPn infection in the development or progression of multiple sclerosis.
• Further research is warranted to elucidate the precise mechanisms linking MPn to MS pathogenesis.